Full Sail Capital »

Alnylam Pharmaceuticals shares owned by Full Sail Capital

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Full Sail Capital from 13F filings

Historical chart of Full Sail Capital investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Full Sail Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Full Sail Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $463k 1.0k 456.00

More positions owned by Full Sail Capital

Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p Mcp Etf (IJH)
Fidelity Covington Trust Msci Info Tech I (FTEC)
Ishares Core Msci Emkt (IEMG)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Select Sector Spdr Tr Technology (XLK)
American Centy Etf Tr Us Eqt Etf (AVUS)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard World Inf Tech Etf (VGT)
Schwab Strategic Tr Us Tips Etf (SCHP)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Vanguard Intl Equity Index F Ftse Smcap Etf (VSS)
Select Sector Spdr Tr Financial (XLF)

View all positions for Full Sail Capital

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
Groupama Asset Managment
State Street Corporation
Baillie Gifford & Co
Geode Capital Management
Dodge & Cox
T. Rowe Price Investment Management
Orbis Allan Gray
Wellington Management Company
Susquehanna International

View all funds holding Alnylam Pharmaceuticals